Crossmark

Active surveillance as the treatment of choice for low-risk prostate cancer: Reliability of results obtained through clinical language processing systems and big data

Crossref DOI link: https://doi.org/10.1016/j.acuroe.2026.501907

Published Print: 2026-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

García-Fuentes, C.

Hernández, V.

Arias, J.

López, M.

de la Peña, E.

Guijarro, A.

Pérez-Fernández, E.

Llorente, C.
License Information

Text and Data Mining valid from 2026-05-01

Text and Data Mining valid from 2026-05-01
More Information

This article is maintained by: Elsevier

Article Title: Active surveillance as the treatment of choice for low-risk prostate cancer: Reliability of results obtained through clinical language processing systems and big data

Journal Title: Actas Urológicas Españolas (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.acuroe.2026.501907

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.acuro.2025.501907

Content Type: article

Copyright: © 2025 AEU. Published by Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Document is current

Any future updates will be listed below